Morning Trend | WEIGAO GROUP faces pressure on support, is a downward trend about to return?

WEIGAO GROUP (1066.HK) maintained pressure at the lower Bollinger Band throughout yesterday, with downward price pressure showing no signs of easing. The pharmaceutical sector continues to be troubled by policy pressures such as price limits and new centralized procurement regulations, which the market interprets as a compression of profitability for mid-range consumable companies, leading to a significant increase in risk-averse sentiment among investors. The apparent buying power from major players is weak, with short-term trading dominated by bargain-hunting funds, and a strong rebound lacks lasting momentum. The MACD continues to expand downward, and the moving average system shows significant resistance, with the price near 4.97 yuan being precarious, indicating a clear inertia for short-term declines. Smaller stocks are following suit with even more intense selling, highlighting a defensive style in the pharmaceutical sector. Attention should be paid to any potential slowdown in centralized procurement policies or self-rescue announcements from the company, as structural rebound speculation may occur. If trading volume continues to shrink and support is lost, the decline may reach a new phase low, with high-position liquidation potentially increasing at any time. The strategy recommendation is to remain on the sidelines, waiting for a recovery in trading volume and marginal policy changes in the sector